Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Home Topics

Law Firm Management

Features

Sales Speak: Keep your Sales Pipeline Flowing

Sue Remley

Everyone who must close sales to perpetuate their own or their firm's/company's practice has a "sales pipeline," even if they are not familiar with the term.

Features

Voice of the Client: Tips from Global In-House Counsel on How to Add Value

Silvia L. Coulter

Common themes have emerged from hundreds of client interviews. Here are some of their top tips ' direct quotes.

Features

Positive Energy, Goal-Setting and Organizational Skills

Bianca Moreiras

How do you stay positive? How do you focus on the positive outcome when you are working in an urgent environment like a law firm?

Features

What Does the Affordable Care Act Mean for Law Firms?

Steven A. Davis

Many law firms have seen an uptick in business since the Patient Protection and Affordable Care Act (ACA), aka Obamacare, was signed into law in 2010. Health care reform has brought clients seeking legal advice on how to comply with the complex health care laws. Business owners might need help revising benefits offerings and updating employee manuals or separation agreements to avoid employment-related lawsuits. And clients in the health care industry may be looking for'

Features

Technology: Friend, Enemy or Frenemy?

Timothy B. Corcoran

A long-time conundrum for law firm partners has been whether to embrace tools and technology that improve efficiency. But can any professional realistically assert to her clients that tools and technology to drive efficiencies are a bad idea?

ATTORNEY MARKETING - What Has the Most Impact?

Allan Colman

A variety of sales techniques for lawyers that have great impact on closing new business.

ATTORNEY MARKETING - What has the Most Impact?

Allan Colman

A variety of sales techniques for lawyers that have great impact on closing new business.

Columns & Departments

Movers & Shakers

ALM Staff & Law Journal Newsletters

Who's doing what; who's going where.

Features

How to Survive a Pension Plan Audit

K. Jennie Kinnevy

This article provides key information on the most frequent problems found with pension plans during employee benefit plan audits, and how you can self-audit your plan for possible compliance issues and options you have to correct them.

Features

Professional Development: The Foundation for Success -- Your Brain Strategy

Paul Silverman

Here are some tips to use your brain more productively.

Need Help?

  1. Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
  2. Need other assistance? email Customer Service or call 1-877-256-2472.

MOST POPULAR STORIES

  • Surveys in Patent Infringement Litigation: The Next Frontier
    Most experienced intellectual property attorneys understand the significant role surveys play in trademark infringement and other Lanham Act cases, but relatively few are likely to have considered the use of such research in patent infringement matters. That could soon change in light of the recent admission of a survey into evidence in <i>Applera Corporation, et al. v. MJ Research, Inc., et al.</i>, No. 3:98cv1201 (D. Conn. Aug. 26, 2005). The survey evidence, which showed that 96% of the defendant's customers used its products to perform a patented process, was admitted as evidence in support of a claim of inducement to infringe. The court admitted the survey into evidence over various objections by the defendant, who had argued that the inducement claim could not be proven without the survey.
    Read More ›
  • In the Spotlight
    On May 9, 2003, the U.S. Attorney's Office for the District of Massachusetts announced that Bayer Corporation, the pharmaceutical manufacturer, had been sentenced and ordered to pay a criminal fine of $5,590,800 stemming from its earlier plea of guilty to violating the Federal Prescription Drug Marketing Act by failing to list with the FDA its drug product, Cipro, that was privately labeled for an HMO. Such listing is required under the federal Food, Drug &amp; Cosmetic Act. The Federal Prescription Drug Marketing Act, Pub. L. 100-293, enacted on April 22, 1988, as modified on August 26, 1992 by the Prescription Drug Amendments (PDA) Pub. L. 102-353, 106 Stat. 941, amended sections 301, 303, 503, and 801 of the Federal Food, Drug, and Cosmetic Act, codified at 21 U.S.C. '' 331, 333, 353, 381, to establish requirements for distributing prescription drug samples.
    Read More ›